REQUEST A DEMO
Total
USD $0.00
Search more companies

Adimmune Corporation (国光生物科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Adimmune Corporation Profile Updated: May 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Adimmune Corporation (国光生物科技股份有限公司) is based in Taiwan, China, with the head office in Taichung City. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on December 22, 1965. There are currently 572 (2023) people employed by Adimmune Corporation (国光生物科技股份有限公司). The company’s latest financial report indicates a net sales revenue increase of 14.16% in Q12026. Its total assets decreased by 6.11% over the same period. The enterprise’s net profit margin increased by 110.66% in 2026.

Headquarters
No.3, Sec. 1, Tanxing Rd.Tanzi Township
Taichung City; Taichung City;

Contact Details: Purchase the Adimmune Corporation (国光生物科技股份有限公司) report to view the information.

Website: http://www.adimmune.com.tw

Basic Information
Total Employees:
Purchase the Adimmune Corporation (国光生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Adimmune Corporation (国光生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Adimmune Corporation (国光生物科技股份有限公司) report to view the information.
Incorporation Date:
December 22, 1965
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Press Relations
Ownership Details
Purchase this report to view the information.
11.31%
Purchase this report to view the information.
3.95%
Purchase this report to view the information.
3.93%
Purchase this report to view the information.
1.87%
Purchase this report to view the information.
0.87%
Subsidiaries
Adimmune B.V (Netherlands)
100%
晉康生命科技有限公司
100%
艾格司農業科技有限公司
100%
Company Performance
Financial values in the chart are available after Adimmune Corporation (国光生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
14.16%
Total Operating Revenue
13.9%
Operating Profit
24.26%
EBITDA
30.04%
Net Profit/Loss for the Period
21.5%
Total Assets
-6.11%
Total Equity
-8.53%
Operating Profit Margin
123.28%
Net Profit Margin
110.66%
Return on Equity (ROE)
0.68%
Debt / Equity
4.82%
Quick Ratio
-0.44%
Cash Ratio
-0.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?